Grifols ^Investors

Grifols is a global healthcare company that has been working since 1909 to improve the health and well-being of people worldwide. The company operates in three segments: Bioscience, Hospital, and Diagnostic. In the Bioscience segment, Grifols focuses on the research, development, production, and commercialization of plasma derivatives. The Diagnostic segment is dedicated to researching, developing, manufacturing, and marketing diagnostic products for laboratory analysis. Grifols is committed to investing in training and development, and their innovative plasma-derived medicines and biopharmaceuticals enable millions of patients to lead more productive lives.